Dolutegravir dose



Dolutegravir Tablets 50mg




 Naivex (Dolotegravir) is an FDA-approved medicine. Is used for the treatment and therapeutic approach of   HIV infection. Naivex is an integrase inhibitor. By integrating blockade, HIV integrase inhibitors prevent their multiplication and can reduce the amount of HIV in the body


Dolutegravir dose tablets | new hiv drugs | aids drugs | hiv med
Dolutegravir Tablets 50mg

Naivex (Dolotegravir) is an HIV-1 antiviral agent. It inhibits HIV integration by binding to the active site and thus blocks the transferring step in the integration of retroviral DNA. This is an essential step in the HIV replication cycle and will result in inhibition of viral activity. 


Side effects:

The most common adverse reactions with Naivex were headache and fatigue and when used with RBV in decompensated cirrhosis were fatigue, hypersensitivity reactions, Effects on serum liver biochemistry in patients Hepatitis B or C, Co-Infection, Fat Redistribution, Immune Reconstitution Syndrome, Sleep Problems, Fatigue.
                                   

No comments:

Post a Comment

MHP

Hepcinat Plus [ Sofosbuvir & Daclatasvir ] Natco Tablets Uses

Hepcinat Plus   - Sofosbuvir 400 mg & Daclatasvir 60 mg Natco. Hepcinat plus contains active ingredients of Sofosbuvir 400mg and Dacl...